Description

Sodium (7-Chloro-2,3-Dihydro-2-Oxo-5-Phenyl-1H-1,4-Benzodiazepin-3-Yl) Succinate is a high-purity pharmaceutical intermediate and active ingredient salt form, critical for ensuring the stability and bioavailability of final drug products. This compound is essential for manufacturers requiring precise chemical composition and reliable supply for regulated production processes. It is primarily utilized in the synthesis of active pharmaceutical ingredients (APIs) within the life sciences and fine chemical sectors.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of benzodiazepine-derived active pharmaceutical ingredients (APIs).
• Active Ingredient Salt Form: Used to improve the solubility, stability, and pharmacokinetic properties of final drug formulations.
• Research & Development: Serves as a critical reference standard and starting material in medicinal chemistry and preclinical research.
• Fine Chemical Synthesis: Employed in multi-step organic synthesis for creating complex, high-value specialty chemicals.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for cGMP-compliant production.
• Analytical Standard: Used for method development, validation, and quality control testing in analytical laboratories.

Basic Information

Product Name	Sodium (7-Chloro-2,3-Dihydro-2-Oxo-5-Phenyl-1H-1,4-Benzodiazepin-3-Yl) Succinate
CAS No.	3693-18-3
Molecular Formula	C19H14ClN2NaO5
Molecular Weight	408.77 g/mol
Synonyms	Sodium Succinate Salt of 7-Chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine; 7-Chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 3-sodium succinate; Sodium Cloxazolam Succinate; Cloxazolam Sodium Succinate; 3693-18-3; UNII-9K4I8B717Y; 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, sodium salt, ester with 1,4-butanedioic acid
EINECS	Contact for details

Quality Control

Our Sodium (7-Chloro-2,3-Dihydro-2-Oxo-5-Phenyl-1H-1,4-Benzodiazepin-3-Yl) Succinate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting specifications suitable for pharmaceutical intermediate use. A comprehensive Certificate of Analysis (COA) documenting purity, related substances, and residual solvents is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and must be kept in a dry environment to prevent degradation. For long-term storage, consider desiccated conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥98.0%
Related Substances (HPLC)	Total impurities ≤2.0%
Loss on Drying	≤2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.